BSE filing, NSE: CORONA. Summary written from the filing by ALFA Finder's alert engine.
Corona Remedies Ltd: key numbers
- Share price
- ₹2,175.00
- Market cap
- ₹13,302 Cr
- Revenue (annual)
- ₹1,403 Cr
- Net profit (annual)
- ₹185.1 Cr
- P/E (TTM)
- 66.8×Sector 48.7×
- Promoter holding
- 69.00%+0.00% QoQ
- FII holding
- 4.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Corona Remedies Ltd
All →Corona Remedies Investor Presentation: Key Takeaways
Q2FY27 revenue ₹441.2Cr (+22.2%), PAT ₹60.3Cr (+15.3%); H1 revenue ₹863.6Cr (+22.0%), PAT ₹120.4Cr (+22.2%). Chronic-led growth, outpacing IPM.
Corona Remedies Q2 FY27 Results: Net Profit ₹60.3 Cr, Up 15.3% YoY
Corona Remedies Ltd reported revenue from operations of ₹441.2 Cr (+22.2% YoY) and net profit of ₹60.3 Cr (+15.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹60.3 Cr · +15.3% YoY
Corona Remedies Business Update
Corona Remedies received GMP Compliance Certification from Brazil's ANVISA for its OSD and Hormone facilities in Ahmedabad. This validates export eligibility to the Brazilian pharmaceutical market.
Corona Remedies Board Meeting Date
Corona Remedies Limited will hold a board meeting on October 30, 2026. The board will consider unaudited financial results for the quarter and half-year ended September 30, 2026.
Corona Remedies Other Announcement
This filing contains quarterly shareholding pattern disclosures for Corona Remedies Ltd. It provides details on share distribution as required by regulatory compliance norms.
Corona Remedies Credit Rating
CARE Ratings has reaffirmed and upgraded the credit ratings assigned to Corona Remedies Limited's bank facilities, as disclosed in the latest regulatory filing.
Other results update announcements
All →IOL Chemicals and Pharmaceuticals Results Update
IOL Chemicals reported record quarterly revenue, EBITDA and profit for Q2 FY27 and half-year results. Standalone growth was strong, with margins expanding year-on-year.
General Insurance Corporation of India Results Update
GIC Re reported half-year ended 30 September 2026 gross premium of Rs.24,703.57 crore and profit after tax of Rs.4,377.66 crore. PAT fell 5.23% year on year.
Affle 3I Results Update
Affle 3i reports Q2 FY2027 revenue of Rs 783.6 crore, up 21.2% y-o-y, with EBITDA up 24.2%. PAT rose 17.4% to Rs 129.8 crore.
Ramkrishna Forgings Results Update
Ramkrishna Forgings' Q2 FY27 revenue rose 55% YoY to ₹1,405 crore, with PAT at ₹71 crore. Figures come from a press release highlights table.
LCC Projects Results Update
LCC Projects reported Q2 FY27 revenue of Rs 8,857 mn, up 34% year-on-year. Order book stood at Rs 81,466 mn.
Reliance Industries Results Update
Reliance Industries' media release reports Q2 FY27 consolidated revenue of ₹3,62,268 crore and EBITDA of ₹62,409 crore. Profit after tax rose 33.8% year-on-year.